Hims & Hers Health (HIMS) Liabilities and Shareholders Equity (2019 - 2026)

Hims & Hers Health's (HIMS) quarterly Liabilities and Shareholders Equity came in at $2.3 billion in Q1 2026, up 154.24% year-on-year from $891.7 million in Q1 2025, and up 5.21% quarter-over-quarter from $2.2 billion in Q4 2025.

Hims & Hers Health (HIMS) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $2.3 billion for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $2.3 billion, up 154.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.5 billion (up 218.14% YoY), and the FY2025 annual result was $2.2 billion, up 204.54% from the prior year.
  • Liabilities and Shareholders Equity came in at $2.3 billion for Q1 2026 at Hims & Hers Health, up from $2.2 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.3 billion in Q1 2026 to a low of $366.3 million in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $448.1 million (2024), against an average of $870.3 million.
  • Across the five-year window, Liabilities and Shareholders Equity decreased 12.9% in 2022 and soared 290.76% in 2025, its largest moves.
  • Hims & Hers Health's Liabilities and Shareholders Equity stood at $366.3 million in 2022, then climbed by 20.43% to $441.2 million in 2023, then soared by 60.37% to $707.5 million in 2024, then jumped by 204.54% to $2.2 billion in 2025, then gained by 5.21% to $2.3 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $2.3 billion (Q1 2026), $2.2 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 401.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.27 Bn
Dec 31, 2025 2.15 Bn
Sep 30, 2025 2.23 Bn
Jun 30, 2025 1.88 Bn
Mar 31, 2025 891.71 Mn
Dec 31, 2024 707.54 Mn
Sep 30, 2024 602.26 Mn
Jun 30, 2024 480.50 Mn
Mar 31, 2024 448.11 Mn
Dec 31, 2023 441.19 Mn
Sep 30, 2023 413.87 Mn
Jun 30, 2023 389.88 Mn
Mar 31, 2023 376.31 Mn
Dec 31, 2022 366.34 Mn
Sep 30, 2022 382.83 Mn
Jun 30, 2022 379.97 Mn
Mar 31, 2022 382.04 Mn
Dec 31, 2021 420.59 Mn
Sep 30, 2021 420.07 Mn
Jun 30, 2021 347.70 Mn